Core Viewpoint - Jianlong Micro-Nano's stock price has experienced fluctuations, with a year-to-date increase of 63.37% but a recent decline of 10.56% over the past five trading days [1] Company Overview - Jianlong Micro-Nano Materials Co., Ltd. is located in Yanshi District, Luoyang City, Henan Province, and was established on July 27, 1998, with its listing date on December 4, 2019 [1] - The company specializes in the research, production, sales, and technical services of molecular sieve adsorbents and catalysts in fields such as medical oxygen, energy chemistry, environmental protection, energy-saving building materials, and refrigeration systems [1] - The main business revenue is derived entirely from product sales, accounting for 100% [1] Financial Performance - For the period from January to September 2025, Jianlong Micro-Nano achieved operating revenue of 590 million yuan, representing a year-on-year growth of 4.34% [1] - The net profit attributable to the parent company was 72.73 million yuan, showing a year-on-year increase of 20.15% [1] Shareholder Information - As of September 30, 2025, the number of shareholders increased by 9.71% to 6,257, while the average circulating shares per person decreased by 8.85% to 15,991 shares [1] - The company has distributed a total of 298 million yuan in dividends since its A-share listing, with 139 million yuan distributed over the past three years [2] Institutional Holdings - As of September 30, 2025, the top ten circulating shareholders include Noan Pioneer Mixed A (320003) as the fifth largest shareholder, holding 4.0588 million shares, an increase of 486,000 shares from the previous period [2] - Noan Preferred Return Mixed A (001743) is the seventh largest shareholder, maintaining its holding of 1.6448 million shares [2]

Investment Rating - The investment rating for the company is maintained as "Outperform" [5]. Core Insights - The company reported a total revenue of 590 million yuan for the first three quarters of 2025, reflecting a year-over-year growth of 4%. The net profit attributable to the parent company was 73 million yuan, up 20% year-over-year [5]. - The second phase of the Thailand Jianlong project is gradually ramping up production, enhancing the company's overseas capacity coordination. The overseas sales revenue reached 155 million yuan, accounting for 26.21% of total revenue, with significant growth in the Thailand operations [5]. - The company is focusing on its core molecular sieve business and increasing R&D investments to expand application scenarios, aiming to improve market share and profitability [5]. Financial Data and Profit Forecast - The company forecasts total revenue of 819 million yuan for 2025, with a year-over-year growth rate of 5.2%. The net profit attributable to the parent company is projected to be 98 million yuan, representing a 31.3% increase [4]. - The gross profit margin is expected to be 29.5% in 2025, with a return on equity (ROE) of 5.5% [4]. - The average price of formed molecular sieve products is revised down from 26,700 yuan/ton to 17,500 yuan/ton for 2025, leading to a downward adjustment of the net profit forecast for 2025 to 98 million yuan [5].

Investment Rating - The report maintains an "Outperform" rating for the company [4]. Core Insights - The company has shown improvement in its operational efficiency, particularly with the gradual ramp-up of its Thailand project, which has enhanced its overseas production capabilities [6]. - The financial performance for the first three quarters of 2025 met expectations, with total revenue of 590 million yuan, a year-on-year increase of 4%, and a net profit of 73 million yuan, reflecting a year-on-year growth of 20% [6]. - The company is focusing on its core business of molecular sieves, increasing R&D investments, and expanding application scenarios to enhance market share and profitability [6]. Financial Data and Profit Forecast - Total revenue is projected to be 819 million yuan in 2025, with a year-on-year growth rate of 5.2% [5]. - The net profit attributable to the parent company is expected to reach 98 million yuan in 2025, representing a year-on-year increase of 31.3% [5]. - The company’s gross margin is forecasted to be 29.5% in 2025, with a return on equity (ROE) of 5.5% [5]. - The average price of formed molecular sieve products is expected to decrease from 26,700 yuan/ton to 17,500 yuan/ton in 2025 [6].

Group 1 - The core viewpoint of the news is that Jianlong Micro-Nano has seen a stock price increase of 5.04%, reaching 40.88 CNY per share, with a total market capitalization of 4.09 billion CNY [1] - Jianlong Micro-Nano specializes in the research, production, sales, and technical services of molecular sieve adsorbents and catalysts in various fields including medical oxygen, energy chemistry, environmental protection, energy-saving building materials, and refrigeration systems [1] - The company's main business revenue is entirely derived from product sales, accounting for 100% of its revenue [1] Group 2 - According to data, the fund "Everbright Prudential Sunshine Three-Month Holding Period Mixed (FOF) A" holds 26,400 shares of Jianlong Micro-Nano, representing 0.2% of the fund's net value, making it the fifth largest holding [2] - The fund has generated an estimated floating profit of approximately 51,700 CNY from its investment in Jianlong Micro-Nano [2] - The fund was established on June 19, 2025, with a current scale of 416 million CNY and has achieved a return of 18.48% since inception [2] Group 3 - The fund managers of "Everbright Prudential Sunshine Three-Month Holding Period Mixed (FOF) A" are Zhao Hao and Zhang Yun, with Zhao having a tenure of 70 days and Zhang having a tenure of 336 days [3] - Zhao Hao's fund has a total asset scale of 526 million CNY, with the best return during his tenure being 3.76% and the worst being 3.69% [3] - Zhang Yun's fund has a total asset scale of 629 million CNY, with the best return during his tenure being 18.48% and the worst being 13.25% [3]

Core Viewpoint - The company, Luoyang Jianlong Micro-Nano New Materials Co., Ltd., is set to hold a Q3 2025 performance briefing on November 18, 2025, to discuss its operational results and financial status with investors [2][3]. Group 1: Meeting Details - The investor briefing will take place on November 18, 2025, from 09:00 to 10:00 [5][6]. - The meeting will be conducted in an interactive online format via the Shanghai Stock Exchange Roadshow Center [3][6]. - Participants can log in to the Roadshow Center to engage in real-time Q&A during the session [7]. Group 2: Participation Information - Investors can submit questions for the briefing from November 11, 2025, to November 17, 2025, by accessing the "Pre-Question Collection" section on the Roadshow Center website or via the company's email [2][7]. - The company will address commonly asked questions during the briefing [2][3]. Group 3: Company Representatives - Key representatives attending the meeting include Chairman Mr. Li Jianbo, Vice Chairman and President Mr. Li Yicheng, and Independent Director Mr. Yan Wenfu [6].

| 证券代码：688357 | 证券简称：建龙微纳 | 公告编号：2025-058 | | --- | --- | --- | | 转债代码：118032 | 转债简称：建龙转债 | | 洛阳建龙微纳新材料股份有限公司 关于召开 2025 年第三季度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 投资者可于 2025 年 11 月 11 日（星期二）至 11 月 17 日（星期一）16:00 前 登录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 ir@jalon.cn 进行提问。公司将在说明会上对投资者普遍关注的问题进行回答。 洛阳建龙微纳新材料股份有限公司（以下简称"公司"）已于 2025 年 10 月 30 日发布公司 2025 年第三季度报告，为便于广大投资者更全面深入地了解公司 2025 年第三季度经营成果、财务状况，公司计划于 2025 年 11 月 18 日（星期二） 09:00-10:00 举行 2025 年第三季度业绩说明会，就投资者关心的问题进行交流。 一、 说明 ...

Market Overview - The chemical products sector experienced a decline of 0.57% on the trading day, with Boyuan Co., Ltd. leading the losses [1] - The Shanghai Composite Index closed at 3986.9, down 0.73%, while the Shenzhen Component Index closed at 13532.13, down 1.16% [1] Stock Performance - Notable gainers in the chemical products sector included: - Hangzhou Oxygen Plant Co., Ltd. (002430) with a closing price of 29.52, up 9.99% and a trading volume of 494,700 shares, totaling 1.43 billion yuan [1] - Pioneer New Materials (300163) closed at 4.93, up 6.94% with a trading volume of 1,542,200 shares, totaling 759 million yuan [1] - Jinrongzi (002407) closed at 26.50, up 6.26% with a trading volume of 2,445,100 shares, totaling 6.408 billion yuan [1] - Major decliners included: - Boyuan Co., Ltd. (301617) closed at 94.00, down 7.66% with a trading volume of 78,600 shares, totaling 763 million yuan [2] - Jinhua New Materials (920015) closed at 58.33, down 7.29% with a trading volume of 132,100 shares, totaling 810 million yuan [2] - Poly United (002037) closed at 10.10, down 6.13% with a trading volume of 247,400 shares, totaling 254 million yuan [2] Capital Flow - The chemical products sector saw a net outflow of 933 million yuan from institutional investors, while retail investors contributed a net inflow of 665 million yuan [2] - The capital flow for specific stocks indicated: - Hangzhou Oxygen Plant Co., Ltd. had a net inflow of 1.52 billion yuan from institutional investors, while retail investors had a net outflow of 948.96 million yuan [3] - Yongtai Technology (002326) experienced a net inflow of 1.25 billion yuan from institutional investors, with a net outflow of 2.22 billion yuan from retail investors [3] - Yahua Group (002497) had a net inflow of 1.08 billion yuan from institutional investors, while retail investors saw a net outflow of 657.87 million yuan [3]

Group 1 - Company Jianlong Micro-Nano reported Q3 performance with revenue of approximately 590 million yuan, a year-on-year increase of 4.34% [1] - The net profit attributable to shareholders was approximately 72.73 million yuan, reflecting a year-on-year increase of 20.15% [1] - Basic earnings per share reached 0.73 yuan, up 21.67% year-on-year [1] Group 2 - As of the report, Jianlong Micro-Nano's market capitalization stands at 3.8 billion yuan [2] - The A-share market has surpassed 4000 points, indicating a significant market resurgence after a decade of stagnation, with technology as a key driver [2]

Core Viewpoint - Jianlong Micro-Nano (688357.SH) reported a revenue of 590 million yuan for the first three quarters of 2025, reflecting a year-on-year growth of 4.34% [1] - The net profit attributable to shareholders reached 72.73 million yuan, marking a year-on-year increase of 20.15% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 69.82 million yuan, showing a year-on-year growth of 31.97% [1] - The basic earnings per share stood at 0.73 yuan [1] Financial Performance - Revenue for the first three quarters: 590 million yuan, up 4.34% year-on-year [1] - Net profit attributable to shareholders: 72.73 million yuan, up 20.15% year-on-year [1] - Net profit after deducting non-recurring gains: 69.82 million yuan, up 31.97% year-on-year [1] - Basic earnings per share: 0.73 yuan [1]

Financial Performance - The company's operating revenue for the third quarter was CNY 212,153,098.40, representing a year-on-year increase of 12.34%[3] - The total profit for the quarter reached CNY 26,932,588.24, a significant increase of 40.47% compared to the same period last year[3] - The net profit attributable to shareholders was CNY 24,052,795.41, reflecting a remarkable growth of 70.22% year-on-year[3] - The net profit after deducting non-recurring gains and losses was CNY 23,864,060.29, which is an increase of 110.88% compared to the previous year[3] - Basic earnings per share for the quarter were CNY 0.24, up 71.43% from the same period last year[4] - For the first three quarters of 2025, the company achieved a revenue of RMB 590.23 million, a year-on-year increase of 4.34%, and a net profit of RMB 72.73 million, up 20.15% year-on-year[13] - In Q3 2025, the company reported a revenue of RMB 212.15 million, representing a year-on-year growth of 12.34% and a quarter-on-quarter increase of 5.80%[13] - Total operating revenue for the first three quarters of 2025 reached ¥590,227,282.05, an increase of 4.9% compared to ¥565,675,765.56 in the same period of 2024[21] - Net profit for the first three quarters of 2025 was ¥72,730,870.82, representing a 20.1% increase from ¥60,532,212.40 in 2024[22] - Earnings per share (EPS) for the first three quarters of 2025 were ¥0.73, compared to ¥0.60 in the same period of 2024, indicating a growth of 21.7%[23] Assets and Liabilities - The total assets at the end of the reporting period amounted to CNY 3,016,579,873.68, an increase of 2.32% from the end of the previous year[4] - As of September 30, 2025, the company's total current assets amounted to RMB 1.47 billion, compared to RMB 1.44 billion at the end of 2024[17] - Total assets as of the end of the reporting period amounted to ¥3,016,579,873.68, an increase from ¥2,948,137,566.53 in the previous year[19] - Total liabilities were reported at ¥1,157,283,364.20, slightly up from ¥1,152,123,201.10 in the previous year[19] - The company's total non-current assets increased to ¥1,546,529,085.56 from ¥1,509,451,758.01, marking a growth of 2.5%[19] Cash Flow - The net cash flow from operating activities for the year-to-date was CNY 62,399,971.84, reflecting a year-on-year increase of 24.16%[3] - Cash inflow from operating activities for the first three quarters of 2025 was $440,703,423.03, compared to $429,722,963.12 in the same period of 2024, representing an increase of approximately 0.23%[25] - Net cash flow from operating activities increased to $62,399,971.84 in 2025 from $50,266,887.89 in 2024, marking a growth of about 24.5%[25] - Cash inflow from investment activities decreased to $1,618,127,229.68 in 2025 from $1,966,656,638.65 in 2024, a decline of approximately 17.7%[26] - Net cash flow from investment activities was negative at -$58,434,491.70 in 2025, compared to -$493,759,731.27 in 2024, indicating an improvement in cash flow[26] - Cash inflow from financing activities totaled $38,000,000.00 in 2025, up from $34,000,000.00 in 2024, reflecting an increase of about 11.8%[26] - Net cash flow from financing activities was -$66,937,545.17 in 2025, compared to -$56,491,711.84 in 2024, showing a worsening in cash flow[26] - The ending cash and cash equivalents balance for 2025 was $156,098,131.11, compared to $96,843,950.30 in 2024, representing an increase of approximately 61.2%[26] Research and Development - The company's R&D investment totaled CNY 8,994,272.62, accounting for 4.24% of operating revenue, a slight decrease of 0.26 percentage points year-on-year[4] - R&D efforts are concentrated on catalyst development for heterogeneous processes, with successful long-cycle verification of new products[15] - Research and development expenses for the first three quarters of 2025 were ¥25,687,785.47, slightly higher than ¥25,527,781.60 in 2024, reflecting a commitment to innovation[21] Strategic Focus - The company is focusing on digitalization and information technology improvements, enhancing operational efficiency and management systems[15] - The company is advancing a major asset restructuring project to enhance its capabilities across the entire value chain from R&D to customer service[15] - The company aims to maintain a steady growth trajectory in 2025, driven by recovering downstream market demand and increased production capacity in Thailand[16] Shareholder Information - The top ten shareholders held a total of 52.61% of the company's shares, with the largest shareholder holding 24.09%[11]